Literature DB >> 18992634

Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma?

Marcelo L Larramendy1, Massimiliano Gentile, Sonia Soloneski, Sakari Knuutila, Tom Böhling.   

Abstract

Leiomyosarcoma (LMS) is the third most common type of soft tissue sarcoma after malignant fibrous histiocytoma (MFH) and liposarcoma. Comparative genomic hybridization (CGH) has shown similar DNA copy number imbalances in LMS and MFH. It has been suggested that both tumors may correspond to different differentiation states of a single tumor entity and that a large proportion of MFHs could correspond to undifferentiated LMS. We report CGH results from 102 MFH and 82 LMS cases, as well as a subsequent clustering analysis. The distribution pattern of DNA copy number changes could not differentiate LMS from MFH, suggesting that most MFHs could represent an ultimate state of tumor progression of LMS. Even if an oncogenic pattern common to LMS and MFH is valid, the genes relevant to smooth muscle cell differentiation may reside in one or more chromosomal imbalances that are not shared by both tumor types. Further explorative analysis identified a small cluster of tumors (9% of the samples: 2 LMS and 10 MFH) characterized by the presence of high-level amplifications at 1p33 approximately p34.3, 17q22 approximately q23, 17q25 approximately qter, 19p, 22p, and 22q, and associated with a higher proportion of tumors located in the thigh (P=0.003) and with male sex (P=0.079).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992634     DOI: 10.1016/j.cancergencyto.2008.06.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

Review 1.  Emerging technologies in paediatric leukaemia.

Authors:  Amanda Dixon-McIver
Journal:  Transl Pediatr       Date:  2015-04

2.  Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.

Authors:  Anne M Mills; Andrew H Beck; Kelli D Montgomery; Shirley X Zhu; Inigo Espinosa; Cheng-Han Lee; Subbaya Subramanian; Christopher D Fletcher; Matt van de Rijn; Robert B West
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 3.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

4.  Genome-wide DNA copy number analysis and targeted transcriptional analysis of canine histiocytic malignancies identifies diagnostic signatures and highlights disruption of spindle assembly complex.

Authors:  Katherine Kennedy; Rachael Thomas; Jessica Durrant; Tao Jiang; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2019-04-23       Impact factor: 5.239

5.  Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.

Authors:  Liaqat Ali; Thomas Helm; Richard Cheney; Jeffrey Conroy; Sheilla Sait; Joan Guitart; Pedram Gerami
Journal:  Int J Clin Exp Pathol       Date:  2010-06-28

6.  Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.

Authors:  Angela D Bhalla; Sharon M Landers; Anand K Singh; Jace P Landry; Michelle G Yeagley; Gabryella S B Myerson; Cristian B Delgado-Baez; Stephanie Dunnand; Theresa Nguyen; Xiaoyan Ma; Svetlana Bolshakov; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Xizeng Mao; Xingzhi Song; Alexander J Lazar; Ian E McCutcheon; John M Slopis; Joseph A Ludwig; Dina C Lev; Kunal Rai; Keila E Torres
Journal:  Lab Invest       Date:  2022-02-28       Impact factor: 5.662

7.  DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

Authors:  Stine H Kresse; Hege O Ohnstad; Bodil Bjerkehagen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

8.  Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.

Authors:  Hiba el Sayadi; Daniel Pissaloux; Laurent Alberti; Severine Tabone-Eglinger; Dominique Ranchere; Anne Valérie Decouvelaere; Eric Tabone; Isabelle Ray-Coquard; Christophe Caux; Jérome Fayette; Jean-Yves Blay
Journal:  Target Oncol       Date:  2013-01-25       Impact factor: 4.493

9.  Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.

Authors:  Elizabeth G Demicco; Genevieve M Boland; Kari J Brewer Savannah; Kristelle Lusby; Eric D Young; Davis Ingram; Kelsey L Watson; Marshall Bailey; Xiangqian Guo; Jason L Hornick; Matt van de Rijn; Wei-Lien Wang; Keila E Torres; Dina Lev; Alexander J Lazar
Journal:  Histopathology       Date:  2015-01-12       Impact factor: 5.087

10.  Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Authors:  A H Beck; C-H Lee; D M Witten; B C Gleason; B Edris; I Espinosa; S Zhu; R Li; K D Montgomery; R J Marinelli; R Tibshirani; T Hastie; D M Jablons; B P Rubin; C D Fletcher; R B West; M van de Rijn
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.